newsfilter
← Latest News
PR Newswire·

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark ...